Human immunodeficiency virus-driven expansion of CD4+CD25+ regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients.
about
Foxp3 represses retroviral transcription by targeting both NF-kappaB and CREB pathwaysHomeostasis and function of regulatory T cells in HIV/SIV infectionLevel, phenotype and activation status of CD4+FoxP3+regulatory T cells in patients chronically infected with human immunodeficiency virus and/or hepatitis C virusInnate and Adaptive Immune Regulation During Chronic Viral InfectionsIncreased sensitivity of CD4+ T-effector cells to CD4+CD25+ Treg suppression compensates for reduced Treg number in asymptomatic HIV-1 infectionHIV-1 and hijacking of the host immune system: the current scenario.HIV's Nef interacts with β-catenin of the Wnt signaling pathway in HEK293 cellsDelayed functional maturation of natural regulatory T cells in the medulla of postnatal thymus: role of TSLP.Suppression of HIV-specific and allogeneic T cell activation by human regulatory T cells is dependent on the strength of signalsP38 MAP kinase signaling is required for the conversion of CD4+CD25- T cells into iTreg.Resting regulatory CD4 T cells: a site of HIV persistence in patients on long-term effective antiretroviral therapyPrevalence and correlates of helminth co-infection in Kenyan HIV-1 infected adults.Regulatory T cells differentially modulate the maturation and apoptosis of human CD8+ T-cell subsets.Gag-Specific CD8 T-Cell Proliferation Is Associated With Higher Peripheral Blood Levels of Transforming Growth Factor-β and Gut-Homing T Cells in Youths Perinatally Infected With Human Immunodeficiency Virus-1: The ANRS-EP38-IMMIP Study.Relationship between regulatory T cells and immune activation in human immunodeficiency virus-infected patients interrupting antiretroviral therapy.FOXP3 expression is upregulated in CD4T cells in progressive HIV-1 infection and is a marker of disease severity.Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS.Virus-induced dysfunction of CD4+CD25+ T cells in patients with HTLV-I-associated neuroimmunological disease.A low T regulatory cell response may contribute to both viral control and generalized immune activation in HIV controllers.Partial regulatory T cell depletion prior to acute feline immunodeficiency virus infection does not alter disease pathogenesisTh17 cells and regulatory T cells in elite control over HIV and SIV.In vivo expansion of CD4CD45RO-CD25 T cells expressing foxP3 in IL-2-treated HIV-infected patientsIn vivo depletion of CD4(+)CD25(hi) regulatory T cells is associated with improved antiviral responses in cats chronically infected with feline immunodeficiency virusCD8+ T-cell dysfunction due to cytolytic granule deficiency in persistent Friend retrovirus infection.In vivo expansion of naive and activated CD4+CD25+FOXP3+ regulatory T cell populations in interleukin-2-treated HIV patientsCD39/adenosine pathway is involved in AIDS progressionHIV-induced T-cell activation/exhaustion in rectal mucosa is controlled only partially by antiretroviral treatmentMycobacterium tuberculosis modulates the gene interactions to activate the HIV replication and faster disease progression in a co-infected hostModeling adaptive regulatory T-cell dynamics during early HIV infection.Animal models for viral infection and cell exhaustion.HIV+ elite controllers have low HIV-specific T-cell activation yet maintain strong, polyfunctional T-cell responses.Comprehensive analysis of frequency and phenotype of T regulatory cells in HIV infection: CD39 expression of FoxP3+ T regulatory cells correlates with progressive disease.The efficacy of T cell-mediated immune responses is reduced by the envelope protein of the chimeric HIV-1/SIV-KB9 virus in vivo.Infection of CD127+ (interleukin-7 receptor+) CD4+ cells and overexpression of CTLA-4 are linked to loss of antigen-specific CD4 T cells during primary human immunodeficiency virus type 1 infection.Poor immune reconstitution in HIV-infected patients associates with high percentage of regulatory CD4+ T cells.HIV-associated chronic immune activation.Expression of a broad array of negative costimulatory molecules and Blimp-1 in T cells following priming by HIV-1 pulsed dendritic cells.Regulatory T cells negatively affect IL-2 production of effector T cells through CD39/adenosine pathway in HIV infectionNormalization of FoxP3(+) regulatory T cells in response to effective antiretroviral therapy.Distinct expression profiles of TGF-beta1 signaling mediators in pathogenic SIVmac and non-pathogenic SIVagm infections.
P2860
Q24323279-9921D62B-2CC8-4357-BF05-339AA95CB3F5Q26995345-754BF7E1-0981-4454-B11F-85073599814FQ27488287-58DF6BEF-EF2E-46DC-AFF9-3C0DC28F78EBQ28079717-8A98E10C-91A6-46AC-B845-B54B7EBC41A8Q28748867-6DE5EB2A-133F-414E-A0B4-1B2453573FF2Q30248405-9E2F84FE-D791-4DE1-87CA-DB0351BA38DFQ31141919-33114F42-C7EF-4E92-8A82-85029F1B968CQ33238306-7616DE9B-49D7-456C-96F3-7A728F9DC7CFQ33359540-32D9F52A-1C50-4EB1-AB84-ACF7505F0BBEQ33373059-655051DD-AB3D-4B67-A495-EDCB6CF51A59Q33373073-507D8891-D923-42FB-8E50-C5753F9D622CQ33548770-6C1D2C9A-ACC8-4CC2-8ED8-B57ADF01C46DQ33611828-2E8C93BB-340E-4C5B-9F3E-17E1B443C145Q33629212-85A16A77-CA94-40AD-8C5B-C2A8E9BA3711Q33640197-5DCC4AC7-35D1-4C72-A2A7-CE89918EC434Q33644550-CEA5C181-7996-4AC0-8199-FCEF178A407AQ33709283-6ADECAC5-B391-4660-8C5D-A2105A1048AEQ33768325-4D4FF969-08B4-4E7C-9E60-0693586CC334Q33815728-4D2A22A2-762A-420D-A535-FF09FE5338E9Q33833910-6E9A00B0-4EA5-4934-9551-6BB46F619D4CQ33838915-7BAE41ED-55A1-46AD-99CE-36857D3CBC22Q33840429-D03D9424-EB14-4A2E-B96B-FC7564C52415Q33889113-E40FCFDD-3D01-415B-8510-87CEA5D989C4Q33911819-277C10F4-1CE2-4F22-83D2-2425359E608DQ33935142-FCDE04C7-B458-43DB-99C5-72ABBD5F7C60Q33959186-671EC463-5EAF-4ABB-B50B-1CAE72A62CB9Q34140484-A785EB1B-4187-4DFF-87DA-7304AF659E5FQ34149784-8854335D-E871-457F-87CD-9FACC819AEEDQ34247040-20A59CD6-2200-4C27-BED0-AD6B0519AD2FQ34267776-B6C2F5BA-1A9B-4756-8CA3-0ACE9AD738A8Q34275430-2FF99073-F277-4AEB-8329-58E2A90D0CDDQ34487847-613F7584-C32A-455F-B355-0BC0A5A1D1C1Q34535707-809F9E41-97F6-4CCC-A7E1-C9A6FA552876Q34571341-9A383BAF-6F41-47B2-B130-4B5E9CA8BDE8Q34600441-8CAD8183-C816-47FC-B9F9-3D6A7F2B5ACDQ34653277-33B81179-FD69-4BA4-A27B-A072087A7E80Q34699537-3343FFB1-C7CC-4E61-86A5-A4A31C79629EQ34711777-12BB133A-609F-439C-A229-7576E8419598Q34764366-C9497C47-37A3-4C20-9E2B-8A7CEF02C979Q34944988-AD9FB637-CACC-4D3A-8DB8-95439CAB79B9
P2860
Human immunodeficiency virus-driven expansion of CD4+CD25+ regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Human immunodeficiency virus-d ...... nses in HIV-infected patients.
@en
Human immunodeficiency virus-d ...... nses in HIV-infected patients.
@nl
type
label
Human immunodeficiency virus-d ...... nses in HIV-infected patients.
@en
Human immunodeficiency virus-d ...... nses in HIV-infected patients.
@nl
prefLabel
Human immunodeficiency virus-d ...... nses in HIV-infected patients.
@en
Human immunodeficiency virus-d ...... nses in HIV-infected patients.
@nl
P2093
P1433
P1476
Human immunodeficiency virus-d ...... nses in HIV-infected patients.
@en
P2093
Cédric Carbonneil
Laurence Weiss
Michèle Balbo
Vladimira Donkova-Petrini
P304
P356
10.1182/BLOOD-2004-01-0365
P407
P577
2004-07-22T00:00:00Z